Chiesi/Protalix
Chiesi/Protalix is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Chiesi/Protalix products.
Drugs from Chiesi/Protalix supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Elfabrio | pegunigalsidase alfa | Metabolic (Fabry) | Fabry disease |
How NPP access to Chiesi/Protalix products works
Reserve Meds sources Chiesi/Protalix products from a US-licensed pharmaceutical wholesale partner, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Chiesi/Protalix
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Chiesi/Protalix.